HERON THERAPEUTICS, INC. /DE/ Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 29.70 million shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2025-03-31 was 29.46M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month |
|---|---|---|
| 2025-06-30 | 29.70M shares 10-Q · filed 2026-08-10 | |
| 2025-03-31 | 29.46M shares 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |